Merck has had an impressive run over the past six months as its shares have beaten the S&P 500 by 6.8%. The stock now trades ...
Gilead Sciences, Inc. GILD announced that the FDA has granted accelerated approval to Hepcludex (bulevirtide-gmod) for adults with chronic hepatitis delta virus (HDV) infection. The approval makes ...
Stocktwits on MSN
HIMS stock extends 3-day rally: Hims & Hers targets GLP-1 gold rush in Canada after Novo Nordisk patent expiry
Hims launched generic Semaglutide in Canada, opening a lower-cost alternative to Novo Nordisk’s Ozempic and Wegovy. ・Health Canada recently approved the first generic semaglutide products in the G7.
Over the next year, countries that are home to 40% of the world’s population are set to get access to Ozempic and Wegovy generics that could cost as little as $15 a month.
President Donald Trump welcomed Fed Chair Kevin Warsh the same way President Ronald Reagan welcomed Fed Chair Alan Greenspan.
Maryland caps Ozempic prices for state and local government health plans, aiming to save $5.8 million annually and improve drug affordability.
Telemedicine can absolutely be an effective way to deliver TRT when performed responsibly, agrees Dr. Miller. “In many ways, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results